Deloitte's 14th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Rebounds After Record Low
/PRNewswire/ -- Key takeaways Projected return on investment in pharma research and development (R&D) in 2023 has risen to 4.1%, climbing back from 2022's...
Source: prnewswire.com